One of the biggest challenges in cancer treatment is that certain cancers reappear after chemotherapy-and an aggressive type ...

One of the biggest challenges in cancer treatment is that certain cancers reappear after chemotherapy—and an aggressive type ...

Artificial intelligence (AI) and socioeconomic factors enhance risk stratification for patients with acute myeloid leukemia (AML) post transplant, aiming to reduce hospital readmissions and disease ...

Amir Fathi, MD, leukemia specialist at Massachusetts General Hospital, discusses the importance of advocacy by both patients ...

The latest update is out from Aptose Biosciences ( (TSE:APS) ).

3."My father recently died of acute myeloid leukemia. Keep in mind, he vehemently refused checkups or doctors' visits for any ...

If there are no dose-limiting toxicities, the company will test the CAR T-cell therapy at higher doses in more patients with FLT3-expressing refractory AML.

(Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the second quarter ended June 30, 2025, which include: Net loss for the second quarter of 2025 was ...

It’s a big step forward in a battle that began unexpectedly, when the little girl — known for her love of all things pink, ...